Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma

SIMPLE SUMMARY: During the last decades, scientific advances in immuno-oncology and a better understanding of tumors’ immune profile led to the development of novel immunotherapeutic strategies, especially immune checkpoint inhibitors. The blockade of PD-1 by monoclonal antibodies (mAbs) is the only...

Descripción completa

Detalles Bibliográficos
Autores principales: Veigas, Florencia, Mahmoud, Yamil D., Merlo, Joaquin, Rinflerch, Adriana, Rabinovich, Gabriel Adrian, Girotti, María Romina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957692/
https://www.ncbi.nlm.nih.gov/pubmed/33804419
http://dx.doi.org/10.3390/cancers13051018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957692/
https://www.ncbi.nlm.nih.gov/pubmed/33804419
http://dx.doi.org/10.3390/cancers13051018

Ejemplares similares